Optima Medical Innovations Corp. (OMIC)
Feb 21, 2025 - OMIC was delisted (reason: acquired by Deerfield)
20.01
0.00 (0.00%)
Inactive · Last trade price on Feb 20, 2025
Singular Genomics Systems Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '21 Sep 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Cash & Equivalents | 0 | 0.11 | 0.06 | 1.47 | 0.02 | 0.01 |
Cash & Short-Term Investments | 0 | 0.11 | 0.06 | 1.47 | 0.02 | 0.01 |
Cash Growth | -99.99% | 65.92% | -95.68% | 6583.85% | 56.06% | - |
Accounts Receivable | 0.03 | 0.03 | 0.17 | 0.19 | 0.03 | 0.01 |
Other Receivables | 0.1 | 0.31 | 0.13 | 0.07 | - | - |
Receivables | 0.14 | 0.34 | 0.3 | 0.57 | 0.03 | 0.01 |
Inventory | 0 | 0 | 0.02 | 0.12 | 0.25 | 0.11 |
Prepaid Expenses | 0.02 | 0.03 | 0.03 | 0.12 | - | - |
Other Current Assets | - | - | - | 0.04 | - | - |
Total Current Assets | 0.16 | 0.47 | 0.41 | 2.32 | 0.3 | 0.13 |
Property, Plant & Equipment | 0.65 | 0.73 | 2.16 | 0.76 | 0.35 | 0.12 |
Long-Term Investments | - | - | - | 1.08 | - | - |
Goodwill | - | - | - | 5.41 | - | - |
Other Intangible Assets | 5.69 | 6.02 | 7.86 | 11.12 | - | - |
Total Assets | 6.51 | 7.22 | 10.43 | 20.69 | 0.66 | 0.25 |
Liabilities
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '21 Sep 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Accounts Payable | 0.88 | 1.1 | 1.56 | 1.83 | 0.16 | 0.33 |
Accrued Expenses | 0.42 | 0.5 | 0.11 | 0.13 | 0.09 | 0.06 |
Short-Term Debt | 0.34 | 0.33 | 0.57 | 0.57 | 0.02 | 1.28 |
Current Portion of Leases | 0.18 | 0.18 | 0.24 | - | - | - |
Other Current Liabilities | 0.75 | 0.97 | 0.32 | - | 0.7 | - |
Total Current Liabilities | 2.58 | 3.07 | 2.8 | 2.53 | 0.96 | 1.67 |
Long-Term Debt | 0.06 | 0.06 | - | - | - | - |
Long-Term Leases | 0.72 | 0.79 | 1.45 | - | - | - |
Total Liabilities | 3.36 | 3.92 | 4.25 | 2.53 | 0.96 | 1.67 |
Shareholders' Equity
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '21 Sep 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Common Stock | 42.29 | 42.29 | 41.79 | 40.74 | 6.03 | 1.49 |
Additional Paid-In Capital | 2.65 | 2.5 | 1.72 | - | - | 0.03 |
Retained Earnings | -46.41 | -46.11 | -42.15 | -24.51 | -8.81 | -2.95 |
Comprehensive Income & Other | 4.63 | 4.63 | 4.83 | 1.93 | 2.48 | 0.01 |
Shareholders' Equity | 3.16 | 3.31 | 6.19 | 18.16 | -0.3 | -1.43 |
Total Liabilities & Equity | 6.51 | 7.22 | 10.43 | 20.69 | 0.66 | 0.25 |
Additional Metrics
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '21 Sep 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Total Debt | 1.3 | 1.35 | 2.25 | 0.57 | 0.02 | 1.28 |
Net Cash (Debt) | -1.3 | -1.24 | -2.19 | 0.9 | 0.01 | -1.27 |
Net Cash Growth | - | - | - | 14559.95% | - | - |
Net Cash Per Share | -0.03 | -0.03 | -0.05 | 0.06 | 0.00 | -0.51 |
Filing Date Shares Outstanding | 50.65 | 50.65 | 44.97 | 40.38 | 9.75 | 12.51 |
Total Common Shares Outstanding | 50.65 | 50.65 | 44.97 | 40.38 | 9.75 | 12.51 |
Working Capital | -2.41 | -2.6 | -2.38 | -0.21 | -0.66 | -1.54 |
Book Value Per Share | 0.06 | 0.07 | 0.14 | 0.45 | -0.03 | -0.11 |
Tangible Book Value | -2.54 | -2.71 | -1.67 | 1.63 | -0.3 | -1.43 |
Tangible Book Value Per Share | -0.05 | -0.05 | -0.04 | 0.04 | -0.03 | -0.11 |
Buildings | - | - | - | - | - | 0.05 |
Machinery | 0.08 | 0.08 | 0.1 | 0.57 | 0.3 | 0.13 |
Leasehold Improvements | 0.09 | 0.09 | 0.5 | 0.44 | 0.18 | - |